Purchase Order 75F40124P00148
- Not listed
- This is a $82,421.32 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a global information analytics company and subsidiary of Reed International PLC. The contract is for perpetual and annual licenses/access to Elsevier's eBooks and subscriptions to support the FDA's research initiatives. The award has no set-aside designation. Elsevier B.V. has received over $60 million in prime federal contracts, primarily from civilian agencies like the...
- This is a $76,649.53 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a global information analytics company, for annual online access to reference modules, ebooks, and journals in the biomedical sciences. The contract was awarded as a sole-source requirement with no set-aside designation. The contract provides the FDA Library with enterprise-wide access to Elsevier's platforms, such as ScienceDirect, Scopus, Reaxys, and Embase, which contain...
- This firm-fixed-price purchase order, valued at $105,243.00, was awarded by the Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS) to Elsevier B.V., doing business as North-Holland (Publishing), for annual access to Elsevier's online eBook collections. Elsevier B.V. is a global information analytics company that predominantly provides the U.S. government with access to its various online databases and platforms, such as ScienceDirect, Scopus, Reaxys,...
- This is a firm-fixed price delivery order awarded by the Office of the Director, a civilian federal agency, to Elsevier Inc. for access to the ScienceDirect journal platform, Scopus citation database, and Embase medical literature database. The award ceiling is $911,876.93 with a period of performance from April 1, 2025 through June 30, 2025. Elsevier holds a larger $80 million single-award indefinite delivery contract with the Library of Congress to provide electronic resources, document...
- This is a federal contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The contract, valued at $3,202,226.57, is for ScienceDirect online subscription services. It is a definitive, firm-fixed-price contract with no set-aside designation. The contract has an ultimate completion date of December 31, 2018 and was awarded on December 31, 2015. Elsevier B.V. has received...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order for an ELSEVIER EMBASE SUBSCRIPTION to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The contract has a potential value of $224,747.00 and provides the FDA with online access to Elsevier's Embase database, which contains scientific literature, patents, and other research publications to support biomedical and...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for perpetual access to the ScienceDirect backfile collections for Cell Press and custom single titles. The contract has a ceiling value of $88,427.00 and a period of performance ending on June 29, 2016. Elsevier B.V. is a global information analytics company that provides scientific, technical, and medical content, including journals, books, and...
- This is a $37,895.88 firm-fixed price purchase order awarded to Elsevier Inc., a leading provider of scientific, technical, and medical information products and services, by the Shared Services Center, a civilian federal agency. The contract is for ScienceDirect online journal subscriptions, databases, e-books, and other digital resources supporting research, education, and healthcare missions across the government. Elsevier serves as the prime contractor on numerous federal awards to deliver...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for an enterprise-wide site license to access the ScienceDirect online database and platform. The $3,446,570.86 contract has a completion date of December 31, 2021 and was awarded on December 19, 2018. Elsevier is a global information analytics company that provides scientific, technical, and medical content to...
- This federal contract award is for a subscription to access Elsevier's PharmaPendium and Pharmacokinetic and Metabolizing Enzyme Modules provided to the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS). The $470,557.91 firm-fixed-price contract was awarded to Elsevier B.V., a global information analytics company based in the Netherlands, on September 16, 2015. The subscription services will be utilized to support the FDA's biomedical...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier Inc., a leading global provider of scientific, technical, and medical information products and services. The contract, valued at $107,500.00, is for the provision of FAERS SOFTWARE - EMBASE, a proprietary medical research platform, over a 4-year period from May 2024 to April 2028. Elsevier holds two significant federal Indefinite Delivery Vehicles (IDVs) with the Library of Congress and the National Institutes of Health, valued at $80 million and $19.3 million respectively, which allow other agencies to efficiently procure Elsevier's electronic resources, document delivery, publications, and specialized access services. This contract award is not associated with a set-aside designation, reflecting Elsevier's status as a sole-source provider of proprietary scientific information products to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 4/25/25 | |
| P00002 | Exercise an Option | $26.3k | 4/15/25 | |
| P00001 | Other Administrative Action | $0 | 5/28/24 | |
| Not listed | Not listed | $25.0k | 5/1/24 |